ÂÜÀòÂÒÂ×

Bernard Kok is an experienced scientist in the field of translational pharmacology and gene therapy, currently serving as the Director of Non-Clinical Development at Ophirex, Inc. since June 2024. Prior to this role, Bernard held positions at Poseida Therapeutics, Inc., where responsibilities included leading translational science efforts for gene therapy programs and managing cross-functional teams to align on preclinical goals and regulatory strategies. Bernard's expertise is supported by a strong academic foundation, holding a PhD in Biochemistry specializing in Lipid Metabolism from the University of Alberta, and a history of impactful research in both postdoctoral and academic roles. Skills in CRO management, pharmacological studies, and biomarker assessment highlight Bernard's capacity to advance complex therapeutic modalities.